Juvenatherapeutics.com
WebbSee what employees say it's like to work at Juvena Therapeutics. Salaries, reviews, and more - all posted by employees working at Juvena Therapeutics. WebbJuvena Therapeutics Main Industry Business Services, Research & Development Website www.juvenatherapeutics.com Contact Information Headquarters 2627 Hanover St, Palo Alto, California, 94304, United States Popular Searches Juvena Therapeutics Inc Juvena Therapeutics Juvena Therapeutics , Inc. Juvena Therpaeutics Juvena Revenue $1.2 M …
Juvenatherapeutics.com
Did you know?
Webb3 jan. 2024 · View Zhihua Li's business profile as Protein Engineer at Juvena Therapeutics. Find contact's direct phone number, email address, work history, and more. Webb9 nov. 2024 · Juvena Therapeutics is a biotech company accelerating the development of therapeutics by unlocking the therapeutic potential of secreted proteins. Secreted proteins are a class of biologics with proven therapeutic potential that has been under-leveraged due to the complexity of identifying and screening such proteins.
Webb8 nov. 2024 · REDWOOD CITY, Calif., November 08, 2024 -- ( BUSINESS WIRE )-- Juvena Therapeutics, Inc. ("Juvena"), a biotechnology company scaling a computational platform to map the therapeutic potential of... Webb8 dec. 2024 · Juvena Therapeutics is a venture-backed biotechnology company unlocking the therapeutic potential of stem cell-secreted proteins and accelerating their development into life-saving therapeutics for chronic and age-related diseases. To learn more about Juvena Therapeutics, visit http://www.juvenatherapeutics.com/ Contact:
Webb9 nov. 2024 · Juvena Therapeutics is a biotech company accelerating the development of therapeutics by unlocking the therapeutic potential of secreted proteins. Secreted proteins are a class of biologics with proven therapeutic potential that has been under-leveraged due to the complexity of identifying and screening such proteins. Webb8 nov. 2024 · Juvena Therapeutics, Inc. (“Juvena”), a biotechnology company scaling a computational platform to map the therapeutic potential of secreted proteins, Juvena …
Webb18 nov. 2024 · Yousef co-founded Juvena Therapeutics, inc. , to pursue her dream to build an innovative biopharmaceutical company that develops novel protein-based medicines that promote tissue regeneration and increase healthspan for age-related and rare degenerative diseases. Industry Biotechnology Revenue $690,000 Employees 50 …
WebbTop Juvena Therapeutics Employees Hanadie Yousef CEO and Co-Founder California, United States View 3 juvenatherapeutics.com gmail.com stanford.edu 2 914560XXXX … pkd malattiaWebbGet Bill Chen's email address (b*****@lenovo.com) and phone number at RocketReach. Get 5 free searches. bank 29210WebbJuvena Therapeutics is a biotechnological company that focuses on the decoding of cell-secreted proteins used in therapeutics for chronic and age-related diseases. It maintains discovery programs and provides a machine learning-enhanced biologics drug discovery and development platform. Type Private Status Active Founded 2024 Website bank 26590025WebbJuvena Therapeutics Inc is a company that operates in the Biotechnology industry. The company is headquartered in Palo Alto, California. Read More Contact Who is Juvena Therapeutics Headquarters 2627 Hanover St, Palo Alto, California, 94304, United States Phone Number (650) 723-2146 Website www.juvenatherapeutics.com Revenue … bank 2d planWebbJuvena Therapeutics is a private company that has been in the industry for 6 years. The company currently specializes in the Biotechnology area. The position of the CEO is … bank 2dWebb1 aug. 2024 · www.juvenatherapeutics.com Ownership Status Privately Held (backing) Financing Status Venture Capital-Backed Primary Industry Drug Discovery Other Industries Other Healthcare Technology Systems Biotechnology Primary Office 640 Galveston Drive Redwood City Palo Alto, CA 94063 United States +1 (650) 000-0000 Juvena … pke austrittWebb14 juni 2024 · Juvena Therapeutics is a computationally driven biopharma startup discovering and developing biologics for rare and chronic degenerative diseases by … bank 27